✦ LIBER ✦

Oxybutynin Extended Release and Tolterodine Immediate Release

✍ Scribed by D. Getsios, Dr J. J. Caro, K. J. Ishak, W. El-Hadi, K. Payne, M. O’Connel, D. Albrecht, W. Feng, D. Dubois

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Canadian economic comparison of extended

✍ Denis Getsios; J.Jaime Caro; K.Jack Ishak; Wissam El-Hadi; Krista Payne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

PUK11 ADHERENCE TO EXTENDED RELEASE TOLT

✍ DA Ollendorf; Z Jumadilova; S Varadharajan; P Girase 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PUK6 ECONOMIC IMPACT OF EXTENDED-RELEASE

✍ D Ollendorf; Z Jumadilova; S Varadharajan; P Girase 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

The cost-effectiveness of solifenacin vs

✍ Linda Cardozo; Andrew Thorpe; Juliet Warner; Manpreet Sidhu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

THE COST-EFFECTIVENESS OF SOLIFENACIN VS

✍ Juliet L. Warner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Oxybutynin Extended-Release

✍ M. Asif A. Siddiqui, Caroline M. Perry, Lesley J. Scott 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 398 KB